PRIA Logo™
119-hr-10359119th CongressWALLET

Priority for Pediatric Cures Act

Sponsored By: Representative Bilirakis, Gus M. [R-FL-12]

Introduced

Summary

This bill would make the authority to award priority review vouchers for rare pediatric disease products permanent. It removes the sunset provision in Section 529(b) so the voucher authority no longer expires, while keeping existing eligibility rules and without creating new funding or administrative changes.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

Permanent priority vouchers for pediatric drugs

If enacted, this bill would strike paragraph (5) of Section 529(b) of the FD&C Act and make the FDA's authority to award priority review vouchers for rare pediatric disease products permanent. Drug makers would continue to be able to receive these vouchers for qualifying pediatric products. Companies would be able to use or sell vouchers to get faster FDA review for other drugs. This would indirectly speed access for some patients while directly benefiting product sponsors. The change would take effect upon enactment.

Sponsors & CoSponsors

Sponsor

Bilirakis, Gus M. [R-FL-12]

FL • R

Cosponsors

  • Rep. Riley, Josh [D-NY-19]

    NY • D

    Sponsored 10/1/2026

  • Rep. McCaul, Michael T. [R-TX-10]

    TX • R

    Sponsored 10/19/2026

  • Rep. Thanedar, Shri [D-MI-13]

    MI • D

    Sponsored 10/26/2026

  • Rep. Vindman, Eugene Simon [D-VA-7]

    VA • D

    Sponsored 10/26/2026

  • Rep. Barragán, Nanette Diaz [D-CA-44]

    CA • D

    Sponsored 9/14/2026

  • Rep. Cammack, Kat [R-FL-3]

    FL • R

    Sponsored 9/14/2026

  • Rep. Auchincloss, Jake [D-MA-4]

    MA • D

    Sponsored 9/14/2026

  • Rep. Kean, Thomas H. [R-NJ-7]

    NJ • R

    Sponsored 9/14/2026

  • Rep. Mullin, Kevin [D-CA-15]

    CA • D

    Sponsored 9/14/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation